Synonyms of Chlamydia
- Chlamydia Trachomatis
- No subdivisions found.
Chlamydia is a sexually transmitted bacterial infection with symptoms similar to those of gonorrhea. Until recently, chlamydia was identified primarily when a certain type of eye infection (trachoma) appeared as a symptom. Initially, the symptoms of chlamydia are usually mild and may not be recognized. In rare cases, chlamydia may have serious complications, if left untreated. Individuals who are sexually active and have multiple sex partners are especially at risk for this disease. Since many people with chlamydia do not realize that they have this infection, they may not seek treatment until serious complications occur. Meanwhile, they may have unknowingly spread the disease to others through sexual activity. Treatment with antibiotics is generally successful; however, prevention is the primary course of action.
Initially, chlamydia may have no noticeable symptoms. Symptoms that affect both males and females include inflammation of the tubes that carry urine from the kidneys to the bladder (urethritis), anal inflammation (proctitis), inflammation of the delicate membranes that line the eyes (conjunctivitis), inflammation of the throat (pharyngitis), and/or or a serious arthritis-like condition known as Reiter's syndrome. (For more information on Reiter's syndrome, choose "Reiter" as your search term in the Rare Disease Database).
When symptoms eventually appear in males, they usually consist of painful urination and a watery discharge from the penis. In some cases, this infection can cause an inflammation of part of the testicles (epididymitis), inflammation of the colon and rectum (proctocolitis), or inflammation of the prostate (prostatitis). Some affected males may experience rectal or urethral strictures, and/or sterility.
In females, chlamydia often begins as an infection or inflammation of the cervix (cervicitis). Itching and burning of the genitals, vaginal discharge, dull pelvic pain and bleeding between menstrual periods may also occur. The infection may then spread to the uterus and/or fallopian tubes. Some affected females may experience inflammation of the mucous membrane lining the uterus (endometritis), inflammation of a certain portion of the uterus (salpingitis), or inflammation of the cetain tissues (i.e., peritoneal capsule) of the liver and of the tissues around the liver (perihepatitis). The infection can subsequently cause infertility and, in some cases, presents the danger of the unusual implantation development of an embryo outside of the uterus (ectopic pregnancy). Inflammation throughout the female reproductive system (pelvic inflammatory disease [PID]) can be a consequence of delayed treatment of chlamydia.
Females who have chlamydial infections during pregnancy have a high risk of spontaneous abortion or stillbirth. Infants who contract the infection from their mothers at birth can get an infection or inflammation of the delicate membranes that line the eyes (conjunctivitis), inflammation of the throat (pharyngitis), and/or pneumonia. Some affected infants may experience chronic impairment of the respiratory system, affecting the ability to breathe. Prompt treatment of the infection in newborns is essential.
Chlamydia is a common infection caused by a bacterium known as chlamydia trachomatis. The disease is sexually transmitted (STD). In addition, the infection can also be transferred from infected mothers to newborn infants.
According to public health officials, four million Americans report incidence of chlamydia each year. Chlamydia can affect both males and females of any age. However, there is a higher prevalence among individuals in their late teens and early twenties. It is estimated that one in six female adolescents and one in ten male adolescents are affected by chlamydia.
It is estimated that of the 155,000 infants born to women with chlamydia each year, 75,000 of then will develop an eye infection (conjunctivitis) and 30,000 eventually receive a diagnosis of pneumonia. It is further estimated that 60 to 80 percent of females and 10 percent of males with chlamydia have no symptoms. As a result, they do not seek treatment and may unknowingly spread the infection.
Chlamydia is one cause of pelvic inflammatory disease (PID) in females. More than 200,000 women are hospitalized in the United States each year with PID and one million are treated for the condition on an outpatient basis. An estimated 11,000 American women become sterile each year and 3,600 have an embryo implant and develop outside of the uterus (ectopic pregnancies) as a consequence of Chlamydia.
The following two venereal disorders are similar to chlamydia. Comparisons may be useful for a differential diagnosis.
Gonorrhea is a sexually transmitted (venereal) disease. It is an infectious disease of the urethra, cervix and rectum and may involve other areas of the body and give rise to serious complications. Gonorrhea is caused by spread of the gonococcus organism Neisseria gonorrhoeae. Initially, the infection is without apparent symptoms. In some cases, this disorder can occur along with chlamydia. Penicillin is the treatment of choice for gonorrhea; however, ampicillin, amoxicillin, tetracycline, or spectinomycin may also be effective therapies. Spread of gonorrhea can be limited through tracing and treating anyone who has been in sexual contact with an infected person. Condoms can prevent transfer of the infection between sexual partners. Prompt medical treatment and followups are recommended for persons who suspect they may have gonorrhea.
Syphilis, also known as lues, is a sexually transmitted disease caused by the spirochete Treponema pallidum. It is characterized by periods of active skin lesions and years of symptomless inactivity (latency). The congenital type of syphilis may be passed from mother to fetus. Syphilis progresses through various stages with different degrees of severity. Penicillin is the treatment of choice; however, other antibiotics are used, especially since recently some forms of syphilis seem to resist penicillin. Vision and hearing complications should be treated concurrently. Spread of the infection can be limited through tracing and treating anyone who has been in sexual contact with an infected person and with the use of condoms during sexual intercourse. Prompt medical treatment and followups are recommended for persons who suspect they may have syphilis. Untreated, the disease may cause neurological damage, dementia, heart disease, and eventually life threatening complications.
The following disorders may be associated with chlamydia as secondary characteristics. They are not necessary for differential diagnosis.
Trachoma can be a symptom of non-venereal infection by the chlamydia bacteria that affects the eyes. It is thought to be transmitted by contaminated fingers rubbing the eyes, infected insects, or anything coming in contact with the eyes that could harbor the chlamydial bacterium. This disorder is the chief cause of blindness in certain underdeveloped areas of the world. In the United States, it has been identified in the mountains of Tennessee and Kentucky, the delta of the Ohio River, South Dakota, Nebraska, and Iowa. The symptoms include swelling of the eyelids with discharge, and enlargement of the tear-producing (lacrimal) glands and nearby lymph nodes. Prompt medical attention is required to avoid blindness that can result if trachoma is left untreated.
Pelvic inflammatory disease (PID), also known as salpingitis, is an infection of the female reproductive organs that can be caused by a variety of bacteria, including the chlamydia type. This term may include infection of the cervix (cervicitis), the lining of the uterus (endometritis), and/or the fallopian tubes and/or the ovaries (oophoritis). This disorder occurs mostly in sexually active women under age 25 years and may be caused by a bacterial infection, intrauterine devices (IUD's), infection during childbirth, or abortion with contaminated devices. Symptoms may include severe lower abdominal pain, fever, vomiting and/or discharge from the cervix. Treatment with antibiotics, or in later stages with surgery, is recommended.
The diagnosis of chlamydia may be confirmed upon a thorough clinical evaluation, characteristic physical findings, a detailed patient history, and specialized laboratory tests (e.g enzyme-linked immunosorbent assay [ELISA]). The use of urinary analysis tests may also be helpful in diagnosing chlamydia.
Use of condoms during sexual activity can help limit the spread of chlamydia; however, medical authorities agree that the key is early detection. Once it is identified, chlamydia can be cured with antibiotics (e.g. tetracycline, erythromycin, aztithromycin). Antibiotic treatment usually lasts for seven to 21 days. Pregnant females or anyone who is being treated for another sexually transmitted disease should consider being tested for chlamydia. Sexually active individuals with multiple sex partners are at greater risk for contracting the infection.
Information on current clinical trials is posted on the Internet at www.clinicaltrials.gov. All studies receiving U.S. government funding, and some supported by private industry, are posted on this government web site.
For information about clinical trials being conducted at the NIH Clinical Center in Bethesda, MD, contact the NIH Patient Recruitment Office:
Tollfree: (800) 411-1222
TTY: (866) 411-1010
For information about clinical trials sponsored by private sources, contact:
Infectious Diseases: Sherwood L. Gorbach, John G. Bartlett, and Neil R. Blacklow, Editors; W.B. Saunders Company, 1992. Pp. 1633-41.
Cecil Textbook of Medicine, 19th Ed.: James B. Wyngaarden and Lloyd H. Smith, Jr., Editors; W.B. Saunders Co., 1992. Pp. 1732-34.
Harrison's Principles of Internal Medicine, 14th Ed.: Kurt J. Isselbacher, M.D. et al., Editors; McGraw-Hill, Inc., 1998. Pp.1055-62.
Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases, 4th Ed.: Gerald L. Mandell, M.D. et al., Editors; Churchill Livingstone Inc., 1995. Pp. 1676-93.
Community-Based Urine Screening for Chlamydia Trachomatis with a Ligase Chain Reaction Assay. J.M. Marrazzo et al.; Ann Intern Med (Nov 1 1997; 127). Pp. 796-803.
Chlamydia is not a Flower. It's a Sexually Transmitted Disease with Devastating Effects: Abbott Health Care Worldwide; Abbott Laboratories, Public Affairs, Dept. 383P, Abbott Park, IL 60064.
Centers for Disease Control Guidelines for Prevention and Control of Chlamydia Trachomatis Infections. Summary and Commentary. T.A. Bell et al.; Ann Intern Med (Apr 1986; 104(4)). Pp. 524-26.
Independent Associations of Bacterial Vaginosis and Chlamydia Trachomatis Infection with Adverse Pregnancy Outcome. M.G. Gravett et al.; JAMA (Oct 10 1986; 256(14)). Pp. 1899-1903.
Epidemiology and Therapy of Chlamydia Trachomatis Infections. W.R. Bowie; DRUGS (May 1984; 27(5). Pp. 459-68.
The information in NORD’s Rare Disease Database is for educational purposes only. It should never be used for diagnostic or treatment purposes. If you have questions regarding a medical condition, always seek the advice of your physician or other qualified health professional. NORD’s reports provide a brief overview of rare diseases. For more specific information, we encourage you to contact your personal physician or the agencies listed as “Resources” on this report.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
Copyright ©1987, 1989, 1998, 2007, 2009
Report last updated: 2009/04/08 00:00:00 GMT+0
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.